Nicotinic autoreceptor function in rat brain during maturation and aging: Possible differential sensitivity to organophosphorus anticholinesterases

Chemico-Biological Interactions

Volumn 142, Issue 3, 2003, Pages 255-268

  Wu, Yi Jun ^a   Harp, Paul ^b   Yan, Xiao Rong ^c   Pope, Carey N ^c  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Acetylcholinesterase; Age related; Chlorpyrifos; Neurotransmitter release

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; ACETYLCHOLINE; ATROPINE; AUTORECEPTOR; CHLORPYRIFOS; CHOLINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; ORGANOPHOSPHATE; ORGANOPHOSPHATE INSECTICIDE; POTASSIUM CHLORIDE; TRITIUM;

ACETYLCHOLINE RELEASE; AGE DISTRIBUTION; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRAIN MATURATION; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; EVOKED RESPONSE; MAXIMUM TOLERATED DOSE; NEUROMODULATION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; SCINTILLATION COUNTING;

ACETYLCHOLINE; AGING; ANIMALS; ANIMALS, NEWBORN; ATROPINE; BRAIN; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; DIMETHYLPHENYLPIPERAZINIUM IODIDE; INSECTICIDES; MECAMYLAMINE; MUSCARINIC ANTAGONISTS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 0037420969     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(02)00121-7     Document Type: Article

References (48)

1. Pope C.N. Organophosphorus pesticides: do they all have the same mechanism of toxicity? J. Toxicol. Environ. Health. 2:1999;161-181.
2. Benke G.M., Murphy S.D. The influence of age on the toxicity and metabolism of methyl parathion and parathion in male and female rats. Toxicol. Appl. Pharmacol. 31:1975;254-269.
3. Mendoza C.E. Toxicity and effects of malathion on esterases of suckling albino rats. Toxicol. Appl. Pharmacol. 35:1976;229-238.
4. Pope C.N., Chakraborti T.K., Chapman M.L., Farrar J.D., Arthun D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology. 68:1991;51-61.
5. Atterberry T.T., Burnett W.T., Chambers J.E. Age-related differences in parathion and chlorpyrifos toxicity in male rats: target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism. Toxicol. Appl. Pharmacol. 147:1997;411-418.
6. Moser V.C., Padilla S. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol. Appl. Pharmacol. 149:1998;107-119.
7. Whitney K.D., Seidler F.J., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol. Appl. Pharmacol. 134:1995;53-62.
8. Moser V.C., Chanda S.M., Mortensen S.R., Padilla S. Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol. Sci. 46:1998;211-222.
9. Zheng Q., Olivier K., Won Y.K., Pope C.N. Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats. Toxicol. Sci. 55:2000;124-132.
10. Mortensen S.R., Chanda S.M., Hooper M.J., Padilla S. Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos. J. Biochem. Toxicol. 11:1996;279-287.
11. Pedata F., Slavikova J., Kotas A., Pepeu G. Acetylcholine release from rat cortical slices during postnatal development and aging. Neurobiol. Aging. 4:1983;31-35.
12. Marchi M., Paudice P., Raiteri M. Autoregulation of acetylcholine release in isolated hippocampal nerve endings. Eur. J. Pharmacol. 73:1981;75-79.
13. Disko U., Haaf A., Heimrich B., Jackisch R. Postnatal development of muscarinic autoreceptors modulating acetylcholine release in the septohippocampal cholinergic system. II. Cell body region: septum. Brain Res. Dev. Brain Res. 108:1998;31-37.
14. Disko U., Haaf A., Gazyakan E., Heimrich B., Jackisch R. Postnatal development of muscarinic autoreceptors in the rat brain: lateral and medial septal nuclei and the diagonal band of Broca. Brain Res. Dev. Brain Res. 114:1999;1-8.
15. Won Y.K., Liu J., Olivier K., Zheng Q., Pope C.N. Age-related effects of chlorpyrifos on acetylcholine release in rat brain. Neurotoxicology. 22:2001;37-46.
16. Araujo D.M., Lapchak P.A., Meaney M.J., Collier B., Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites. J. Neurosci. 10:1990;3069-3078.
17. Lena C., Changeux J.P., Mulle C. Evidence for 'preterminal' nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13:1993;2680-2688.
18. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716.
19. McGehee D.S., Heath M.J.S., Gelber S., Devay P., Role L.W. Nicotinic enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
20. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
21. Sorenson E.M., Shiroyama T., Kitai S.T. Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat. Neuroscience. 87:1998;659-673.
22. Rocha E.S., Swanson K.L., Aracava Y., Goolsby J.E., Maelicke A., Albuquerque E.X. Paraoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 278:1996;1175-1187.
23. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
24. Wilkie G.I., Hutson P., Sullivan J.P., Wonnacott S. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem. Res. 21:1996;1141-1148.
25. Albuquerque E.X., Alkondon M., Pereira E.F., Castro N.G., Schrattenholz A., Barbosa C.T., Bonfante-Cabarcas R., Aracava Y., Eisenberg H.M., Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther. 280:1997;1117-1136.
26. Beani L., Bianchi C., Ledda F. The effect of tubocurarine on acetylcholine release from the motor nerve terminals. J. Physiol. (Lond.). 174:1964;172-183.
27. Richardson I.W., Szerb J.C. The release of labelled acetylcholine and choline from cerebral cortical slices stimulated electrically. Br. J. Pharmacol. 52:1974;499-507.
28. Marchi M., Raiteri M. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of 'impaired' cholinergic presynaptic function. J. Neurochem. 67:1996;1974-1981.
29. Katz E.J., Cortes V.I., Eldefrawi M.E., Eldefrawi A.T. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities. Toxicol. Appl. Pharmacol. 146:1997;227-236.
30. Corringer P.J., Le Novere N., Changeux J.P. Nicotinic receptors at the amino acid level. Annu. Rev. Pharmacol. Toxicol. 40:2000;431-458.
31. 2+ ions in their function and desensitization. Neurochem. Int. 34:1999;319-328.
32. Karanth S., Pope C.N. Carboxylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats. Toxicol. Sci. 58:2000;282-289.
33. Johnson C.D., Russell R.L. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64:1975;229-238.
34. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-270.
35. Raiteri M., Leardi R., Marchi M. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J. Pharmacol. Exp. Ther. 228:1984;209-214.
36. H. Motulsky, Analyzing Data with GraphPad Prism, GraphPad Software, Inc, San Diego, CA, 1999, 193 pp.
37. SAS. JMP User's Guide, Version 3, SAS Institute, Cary, NC, 1995.
38. 3H]acetylcholine release from mouse cerebral cortical synaptosomes. J. Neurochem. 43:1984;1593-1598.
39. Nordberg A., Romanelli L., Sundwall A., Bianchi C., Beani L. Effect of actue and subchronic nicotine treatment on cortical acetylcholine release and on nicotinic receptors in rats and guinea-pigs. Br. J. Pharmacol. 98:1989;71-78.
40. Freund R.K., Jungschaffer D.A., Collins A.C. Nicotine effects in mouse hippocampus are blocked by mecamylamine, but not other nicotinic antagonists. Brain Res. 511:1990;187-191.
41. Ochoa E.L.M., Chattopadhyay A., McNamee M.G. Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators. Cell. Mol. Neurobiol. 9:1989;141-178.
42. Ochoa E.L.M., Li L., McNamee M.G. Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine. Mol. Neurobiol. 4:1990;251-287.
43. Auerbach A., Akk G. Desensitization of mouse nicotinic acetylcholine receptor channels: a two-gate mechanism. J. Gen. Physiol. 112:1998;181-197.
44. Rao T.S., Correa L.D., Lloyd G.K. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors. Neuropharmacology. 36:1997;39-50.
45. Rowell P.P., Duggan D.S. Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine. Neuropharmacology. 37:1998;103-111.
46. Milburn C.M., Prince D.A. Postnatal development of cholinergic presynaptic inhibition in rat hippocampus. Brain Res. Dev. Brain Res. 74:1993;133-137.
47. Leeson P.D., Iverson L.L. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J. Med. Chem. 37:1994;4053-4067.
48. Zwart R., Vijverberg H.P.M. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Mol. Pharmacol. 52:1997;886-895.